Stempeutics Research
Tracked across 1 events · 6 articles · First seen Sep 10, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
India's India — Drugs Controller General of India (DCGI) has approved an allogeneic bone marrow-derived mesenchymal stem cell therapy for knee osteoarthritis, marking the first time such an approved regenerative therapy enters clinical practice in…
Impact: Stempeutics Research manufactures the DCGI-approved stem cell therapy, making it a key beneficiary of the first approved regenerative knee osteoarthritis treatment in India. The approval strengthens its position in the regenerative medicine market.
Sep 10, 2026 · 6 articles
80
India — Drugs Controller General of India approved stem cell therapy Stempeutics ResearchIndia Approves Stempeutics...
ERGEN INTELLIGENCE
Track Stempeutics Research live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard